High-Grade Undifferentiated Carcinoma | ||
Antibody | Prostate | Urothelial |
PSA | 68-94% | 0% |
PAP | 78-95% | 0% |
PSMA | > 95% (best) | 0% |
HMCK(34βE12) | 6-10% | 65-100% |
Uroplakin-3 | 0% | 57-60% |
Thrombomodulin | 0% | 49-69% |
p63 | 0-18% | 70-75% |
CD57 | 94% | 17% |
S100p | 0-1% | 78-86% |
GATA3 | 0-3% | 67% |
Enteric-type Adenocarcinoma | ||
Antibody | Bladder | Colon |
CK7(+)/CK20(+) | 24% | 8% |
CK7(+)/CK20(-) | 41% | 0% |
CK7(-)/CK20(+) | 29% | 82% |
CK7(-)/CK20(-) | 6% | 10% |
CDX-2 | 47-100% | 99-100% |
β-catenin | 0% | 81% (best) |
Villin | 65-100% | 82-98% |
Thrombomodulin | 59% | 0% |
Spindle Cell Proliferations: Adults | ||||
Antibody | Pseudosarcomatous Myofibroblastic Proliferation | Sarcomatoid Carcinoma | Leiomyosarcoma | |
Actin-sm | 63-100% | 15-80% | 43-100% | |
Desmin | 27-80% | 0-40% | 0-60% | |
h-caldesmon | 0-66% | ND | 100% | |
PAN-CK(AE1/AE3) | 36-89% | 67-100% | 0-38% | |
EMA/MUC1 | 0-50% | 50-100% | 0-12% | |
ALK1 | 75-89% | 0% | 10% | |
p63 | 0% | 50% | 23% | |
HMCK(34βE12) | 0% | 25-27% | 0% |
Spindle Cell Proliferations: Children | |||
Antibody | Pseudosarcomatous Myofibroblastic Proliferation | Rhabdomyosarcoma | |
Actin-sm | 63-100% | 97% | |
Desmin | 27-80% | 97% | |
MyoD1 | 0% | 100% | |
Myogenin | 0% | 100% | |
ALK1 | 75-89% | 20% |
Bladder Neoplasms with Nested Morphology | ||||
Antibody | Paraganglioma | Carcinoid | Urothelial Carcinoma | Melanoma |
PAN-CK(AE1/AE3) | – | + | + | – |
Synaptophysin | + | + | – | – |
Chromogranin | + | + | – | – |
S100 | + (sustentacular cells) | – | – | + |
ND – No Data |
Flat Urothelial Lesions with Atypia (URO3 Cocktail) | |||
Antibody | Normal | Reactive | CIS |
CK20 (cytoplasmic, red) | Umbrella layer only | Umbrella layer only | Full thickness urothelium |
CD44 (membranous, brown) | Basal layer only | Increased expression in intermediate cells to full thickness urothelium | Basal layer only or loss of expression |
p53 (nuclear, brown) | Rare cells; weak reactivity | Rare cells; weak reactivity | Diffuse, strong reactivity |
URO3 is a antibody cocktail comprised of three antibodies: CK20, CD44, and p53. |